Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Lipella Pharmaceuticals Inc

LIPO
4,02
0,00 (0,00%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/2/202518:10APSBiotech Rips On Topline Analysis
11/2/202515:28EDGAR2Form 8-K - Current report
11/2/202511:46GLOBELipella Pharmaceuticals Reports Positive Topline Phase 2a..
10/2/202523:35EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
06/2/202512:00GLOBELipella Pharmaceuticals Granted FDA Approval for Expanded..
18/1/202502:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202512:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/1/202514:42EDGAR2Form 8-K - Current report
10/1/202519:24GLOBESpartan Capital Securities, LLC Serves as Sole Placement..
07/1/202523:25EDGAR2Form S-3 - Registration statement under Securities Act of..
06/1/202523:25EDGAR2Form 8-K - Current report
04/1/202503:25EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
04/1/202503:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:11EDGAR2Form 8-K - Current report
28/12/202403:31EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
28/12/202403:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202422:05EDGAR2Form 8-K - Current report
20/12/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202422:05EDGAR2Form 8-K - Current report
10/12/202415:29EDGAR2Form 8-K - Current report
06/12/202422:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/12/202422:05EDGAR2Form 8-K - Current report
03/12/202414:30GLOBELipella Pharmaceuticals Announces Publication in CUREUS on..
21/11/202411:30GLOBELipella Pharmaceuticals Announces Completion of First Cohort..
14/11/202423:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202423:09EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202423:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202411:30GLOBELipella Pharmaceuticals Secures Extended Market Exclusivity..
07/11/202423:01EDGAR2Form 8-K - Current report
01/11/202422:24EDGAR2Form PRE 14A - Other preliminary proxy statements
01/11/202422:00EDGAR2Form 8-K - Current report
01/11/202421:30GLOBELipella Pharmaceuticals Announces 1-for-8 Reverse Stock..
29/10/202413:30GLOBELipella Pharmaceuticals to Present at 2024 Spartan Capital..
18/10/202422:05EDGAR2Form 8-K - Current report
17/10/202423:00EDGAR2Form SC 13D/A - General Statement of Acquisition of..
17/10/202423:00EDGAR2Form SC 13D/A - General Statement of Acquisition of..
15/10/202411:00GLOBELipella Pharmaceuticals Announces U.S. Patent Allowance for..
09/10/202416:47GLOBELipella Pharmaceuticals to Present at 2024 Maxim Healthcare..
25/9/202414:30GLOBEPRISM MarketView Features Q&A with Dr. Michael Chancellor:..
24/9/202414:00GLOBELipella Pharmaceuticals Reports Encouraging Early..
11/9/202423:10EDGAR2Form 8-K - Current report
27/8/202414:00GLOBELipella Pharmaceuticals to Participate at H.C. Wainwright's..
23/8/202422:45EDGAR2Form 8-K - Current report
22/8/202411:00GLOBELipella Pharmaceuticals Launches Innovative Registry to..
21/8/202411:00GLOBELipella Pharmaceuticals Unveils Advanced Bladder Imaging..
19/8/202422:05EDGAR2Form SC 13D/A - General Statement of Acquisition of..
13/8/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202414:25EDGAR2Form DEF 14A - Other definitive proxy statements
12/8/202411:00GLOBELipella Pharmaceuticals Doses First Two Patients in Phase 2a..
06/8/202422:50EDGAR2Form 8-K - Current report
Apertura: 4,14 Min: 3,69 Max: 4,14
Chiusura: 4,02

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network